Clinical Trial Update: Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing a therapy aimed at prolonging metastasis-free survival in men with hormone-refractory prostate cancer has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-refractory Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Amgen | Conditions: Hormone Refractory Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-04-06